Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. 2003

Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
Department of Intensive Care, Austin & Repatriation Medical Centre, Melbourne, Vic., Australia.

OBJECTIVE To determine the impact of replacement fluid infusion site on filter life and azotemic control during continuous veno-venous hemofiltration (CVVH). METHODS Pre-dilution CVVH was conducted from February 2001 to December 2001 and then practice was changed to post-dilution (from January 2002 to July 2002). Filter life was prospectively observed and the following data obtained for each filter: starting date and time, ending date and time, heparin use, heparin dose and protamine use. Daily creatinine, urea, INR, APTT and platelet count were also collected. RESULTS Forty-eight patients were studied (33 in pre-dilution and 15 in post-dilution) for a total of 309 filters (202 in pre-dilution and 107 in post-dilution). The median filter life was significantly shorter in the post-dilution period (18.0 vs. 13.0 h, p = 0.021). Multivariate linear regression analysis showed that pre-dilution was a significant independent predictor of increased filter life (p = 0.029), together with platelet count (p = 0.0035) and heparin dose (p = 0.046). There was no significant improvement in daily creatinine and/or urea reduction in the post-dilution period (% Delta creatinine: 7.9 vs. 10.2%/day, p = 0.99, urea: 5.4 vs. 9.7%/ day, p = 0.78). CONCLUSIONS Post-dilution was associated with reduced filter life without any beneficial effect on daily changes in urea and creatinine levels. Pre-dilution appears a preferable technical approach to CVVH.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005374 Filtration A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Filtrations
D005440 Fluid Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS. Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
January 2003, Nephron. Clinical practice,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
February 1979, Clinical nephrology,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
May 2000, Renal failure,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
January 2019, The International journal of artificial organs,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
April 1991, Critical care medicine,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
January 2017, Blood purification,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
January 2003, The International journal of artificial organs,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
March 2018, Military medicine,
Shigehiko Uchino, and Nigel Fealy, and Ian Baldwin, and Hiroshi Morimatsu, and Rinaldo Bellomo
February 2001, Intensive care medicine,
Copied contents to your clipboard!